Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers

RALEIGH, N.C., July 7, 2021 /PRNewswire/ -- Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced today that it has launched FastBack Bio, the first of multiple next-generation cell and gene therapy platform companies that...

from PR Newswire: https://ift.tt/3dObvHw